| CVLEX | VIVAX | CVLEX / VIVAX | |
| Total Expense Ratio | 1.00 | 0.17 | 588% |
| Annual Report Gross Expense Ratio | 2.71 | 0.17 | 1,594% |
| Fund Existence | 14 years | 34 years | - |
| Gain YTD | 16.579 | 13.350 | 124% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 32.1M | 245B | 0% |
| Annual Yield % from dividends | 1.02 | 1.76 | 58% |
| Returns for 1 year | 30.37 | 25.00 | 121% |
| Returns for 3 years | 41.76 | 56.38 | 74% |
| Returns for 5 years | 23.65 | 59.70 | 40% |
| Returns for 10 years | 60.48 | 163.77 | 37% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MDFGX | 38.77 | N/A | N/A |
| BlackRock Capital Appreciation Inv A | |||
| MDDLX | 9.46 | N/A | N/A |
| MassMutual Diversified Value Adm | |||
| VISVX | 57.18 | N/A | N/A |
| Vanguard Small Cap Value Index Inv | |||
| TQTIX | 19.81 | N/A | N/A |
| AMG TimesSquare International SmallCap I | |||
| AVENX | 18.81 | N/A | N/A |
| Avantis® Emerging Markets Equity G | |||